Yoshihiro Oda

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Drug Administration

Top Venues

Therapeutic innovation & regulatory science

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshihiro Oda, Mamoru Narukawa
Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval. Therapeutic innovation & regulatory science (2024)
Yoshihiro Oda, Mamoru Narukawa
Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval. Therapeutic innovation & regulatory science 58 (2) (2024)
Yoshihiro Oda, Mamoru Narukawa
Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval. Therapeutic innovation & regulatory science 58 (2) (2024)
Yoshihiro Oda, Mamoru Narukawa
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial. BMC cancer 22 (1) (2022)